磁共振灌注成像评估瑞加德松开放血脑屏障的初步研究

摘要
图/表
参考文献(19)
相关文章 (15)

全文: PDF (0 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的：利用MR灌注成像（MR PWI）评价瑞加德松对兔脑血脑屏障的开放程度。方法：50只新西兰大白兔随机分为实验组（A组）和对照组（B组），分别经耳缘静脉注入瑞加德松和生理盐水，延迟10 min后行MR PWI扫描。比较分析两组感兴趣区rCBF、rCBV、TTP及MTT参数值差异（配对t检验）。各组随机选5只兔子，图像采集后即刻静脉注入2%伊文氏蓝，1小时后处死取脑组织观察蓝染情况。结果：Ａ组感兴趣区rCBF、rCBV较B组明显增高，脑组织蓝染明显，有统计学差异（P<0.05），TTP值、MTT值在两组间无明显差异（P＞0.05）。结论：MR PWI的参数rCBF和rCBV可在体监测瑞加德松开放血脑屏障的程度。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	常灿灿1
	周军2
	杨本强1
	李虹易1
	徐志华1
	林森1
	段阳1

关键词 ：血脑屏障, 磁共振成像

Abstract：Objective: To evaluate the level of regadenoson-induced blood-brain barrier opening of healthy rabbits via MR perfusion weighted imaging(MR PWI) scan. Methods: Fifty New Zealand white rabbits were randomly divided into experimental group(group A) and control group(group B). The regadenoson and normal saline were injected intravenously into ear margin separately, after 10 minute, MR PWI scan was performed. Then rCBF, rCBV, TTP and MTT of the region of interest of each group were acquired and compared statistically(paired t test). Five cases of each group choosed randomly were injected with 2% Evens blue intravenously posterior to imaging. After one hour of infusion, all the animals were killed. Their brains were examined for the determination of Evens blue distribution. Results: The rCBF and rCBV values and the staining with Evens blue of group A were significantly higher than those of group B(P<0.05). There were no significant differences of TTP and MTT values between group A and B(P>0.05). Conclusion: The parameters(rCBF, rCBV) of MR PWI scan can monitor the level of regadenoson-induced blood-brain barrier opening in vivo.

Key words： Blood-brain barrier Magnetic resonance imaging

收稿日期: 2016-01-07

PACS:	Ｒ338
	Ｒ972
	Ｒ445.2

基金资助:本文课题受辽宁省科技攻关基金项目（编号：2012225019）资助。

通讯作者: 段阳，沈阳军区总医院放射科，110016。E-mail：duanyang100@126.com

作者简介: 常灿灿（1991-），女，安徽亳州人，医师。E-mail：853348688@qq.com

引用本文:

常灿灿1，周军2，杨本强1，李虹易1，徐志华1，林森1，段阳1. 磁共振灌注成像评估瑞加德松开放血脑屏障的初步研究[J]. 中国临床医学影像杂志, 2016, 27(10): 690-693.
CHANG Can-can1, ZHOU Jun2, YANG Ben-qiang1, LI Hong-yi1, XU Zhi-hua1, LIN Sen1, DUAN Yang1. Preliminary study on assessment of regadenoson-induced blood-brain barrier opening by MR perfusion weighted imaging. JOURNAL OF CHINA MEDICAL IMAGING, 2016, 27(10): 690-693.

链接本文:

http://www.jccmi.com.cn/CN/ 或 http://www.jccmi.com.cn/CN/Y2016/V27/I10/690

[1]Daneman R, Barres BA. The blood-brain barrier-lessons from moody flies[J]. Cell, 2005, 123(1): 9-12.
[2]Agarwal V, DePuey EG. Regadenoson and seizures: a real clinical concern[J]. J Nucl Cardiol, 2014, 21(5): 869-870.
[3]Rajadhyaksha M, Boyden T, Liras J, et al. Current advances in delivery of biotherapeutics across the blood-brain barrier[J]. Curr Drug Discov Technol, 2011, 8(2): 87-101.
[4]Abbott NJ, Patabendige AA, Dolman DE, et al. Structure and function of the blood-brain barrier[J]. Neurobiol Dis, 2010, 37(1): 13-25.
[5]Hossain S, Akaike T, Chowdhury EH. Current approaches for drug delivery to central nervous system[J]. Curr Drug Deliv, 2010, 7(5): 389-397.
[6]Pardridge WM. The blood-brain barrier: bottleneck in brain drug development[J]. NeuroRx, 2005, 2(1): 3-14.
[7]Marchi N, Angelov L, Masaryk T, et al. Seizure-promoting effect of blood-brain barrier disruption[J]. Epilepsia, 2007, 48(4): 732-742.
[8]Cook AM, Mieure KD, Owen RD, et al. Intracerebroventricular administration of drugs[J]. Pharmacotherapy, 2009, 29(7): 832-845.
[9]Jenne JW. Non-invasive transcranial brain ablation with high-intensity focused ultrasound[J]. Front Neurol Neurosci, 2015, 36: 94-105.
[10]Yu YJ, Atwal JK, Zhang Y, et al. Therapeutic bispecific antibodies cross the blood-brain barrier in nonhuman primates[J]. Sci Transl Med, 2014, 6(261): 261.
[11]Witt KA, Gillespie TJ, Huber JD, et al. Peptide drug modifications to enhance bioavailability and blood-brain barrier permeability[J]. Peptides, 2001, 22(12): 2329-2343.
[12]赵博贤，毕云科，李宪峰，等. 腺苷受体与血脑屏障通透性研究进展[J]. 临床神经外科杂志，2013，10（4）：248-250.
[13]Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes[J]. Microvasc Res, 2009, 77(1): 53-63.
[14]Carman AJ, Mills JH, Krenz A, et al. Adenosine receptor signaling modulates permeability of the blood-brain barrier[J]. J Neurosci, 2011, 31(37): 13272-13280.
[15]Villringer A, Rosen BR, Belliveau JW, et al. Dynamic imaging with lanthanide chelates in normal brain: contrast due to magnetic susceptibility effects[J]. Magn Reson Med, 1988, 6(2): 164-174.
[16]Provenzale JM, Wang GR, Brenner T, et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging[J]. Am J Roentgenol, 2002, 178(3): 711-716.
[17]Morita N, Wang S, Chawla S, et al. Dynamic susceptibility contrast perfusion weighted imaging in grading of nonenhancing astrocytomas[J]. J Magn Reson Imaging, 2010, 32(4): 803-808.
[18]周丽，付旷，郭丽丽，等. 3.0T磁共振灌注加权成像在脑胶质瘤诊断中的价值[J]. 中国实验诊断学，2013，17（2）：275-278.
[19]陆娜，冯晓源，邸悦，等. CT灌注成像评价人脑胶质瘤肿瘤血管生成[J]. 中国医学计算机成像杂志，2014，20（6）：481-484.